A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06921850 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06921850
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2026-12-21
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.